01 1Shandong Anhong Pharmaceutical
01 1REGORAFENIB
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-11-07
Pay. Date : 2025-09-08
DMF Number : 41596
Submission : 2025-09-28
Status : Active
Type : II
20
Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is REGORAFENIB, with a corresponding US DMF Number 41596.
Remarkably, this DMF maintains an Active status since its submission on September 28, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 07, 2025, and payment made on September 08, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
